• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ha-ras癌基因在人类泌尿系统肿瘤中因体细胞改变而被激活。

Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumours.

作者信息

Fujita J, Yoshida O, Yuasa Y, Rhim J S, Hatanaka M, Aaronson S A

出版信息

Nature. 1984;309(5967):464-6. doi: 10.1038/309464a0.

DOI:10.1038/309464a0
PMID:6328318
Abstract

DNA-mediated gene transfer (transfection) studies using NIH 3T3 cells as recipients have demonstrated the presence of transforming genes (oncogenes) in diverse human tumours. A large proportion of oncogenes so far detected by DNA transfection are related to the Ha-ras onc gene of Harvey (and BALB) murine sarcoma viruses (MSV), Ki-ras, the oncogene of Kirsten MSV, and a third member of the ras gene family, N-ras. Individual tumours of many different organs have been associated with the activation of members of the ras gene family. We now present the first systematic survey of human urinary tract tumours processed immediately after surgery, as well as normal tissues from the same patients, to detect the presence of such genes. We demonstrate activation of Ha-ras as an oncogene in around 10% of randomly selected urinary tract tumours as well as direct evidence that oncogene activation is the result of a somatic event which is selected for within the tumour cell population.

摘要

以NIH 3T3细胞作为受体的DNA介导的基因转移(转染)研究表明,多种人类肿瘤中存在转化基因(癌基因)。到目前为止,通过DNA转染检测到的大部分癌基因与哈维(和BALB)鼠肉瘤病毒(MSV)的Ha-ras癌基因、柯尔斯滕MSV的癌基因Ki-ras以及ras基因家族的第三个成员N-ras相关。许多不同器官的个别肿瘤与ras基因家族成员的激活有关。我们现在首次对手术后立即处理的人类泌尿系统肿瘤以及同一患者的正常组织进行系统调查,以检测此类基因的存在。我们证明,在大约10%的随机选择的泌尿系统肿瘤中,Ha-ras作为癌基因被激活,并且有直接证据表明癌基因激活是肿瘤细胞群体中选择的体细胞事件的结果。

相似文献

1
Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumours.Ha-ras癌基因在人类泌尿系统肿瘤中因体细胞改变而被激活。
Nature. 1984;309(5967):464-6. doi: 10.1038/309464a0.
2
A novel transforming gene in a human malignant melanoma cell line.
Nature. 1984;311(5987):671-3. doi: 10.1038/311671a0.
3
Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tumors.影响人类泌尿道肿瘤中ras原癌基因的分子改变频率。
Proc Natl Acad Sci U S A. 1985 Jun;82(11):3849-53. doi: 10.1073/pnas.82.11.3849.
4
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene.人EJ膀胱癌细胞癌基因是哈维肉瘤病毒ras基因的同源物。
Nature. 1982 Jun 10;297(5866):474-8. doi: 10.1038/297474a0.
5
Biological properties of human c-Ha-ras1 genes mutated at codon 12.在密码子12处发生突变的人类c-Ha-ras1基因的生物学特性。
Nature. 1984;312(5989):71-5. doi: 10.1038/312071a0.
6
[Detection and preliminary characteristics of the transforming gene (oncogene) of Ha-ras type in human stomach cancer].[人胃癌中Ha-ras型转化基因(癌基因)的检测及初步特性]
Mol Biol (Mosk). 1986 Nov-Dec;20(6):1513-21.
7
Transforming genes of human hematopoietic tumors: frequent detection of ras-related oncogenes whose activation appears to be independent of tumor phenotype.人类造血肿瘤的转化基因:频繁检测到与ras相关的癌基因,其激活似乎与肿瘤表型无关。
Proc Natl Acad Sci U S A. 1983 Aug;80(16):4926-30. doi: 10.1073/pnas.80.16.4926.
8
Activating missense mutations in Ha-ras-1 genes in a malignant subset of bladder lesions induced by N-butyl-N-(4-hydroxybutyl)nitrosamine or N-[4-(5-nitro-2-furanyl)-2-thiazolyl]formamide.
Mol Carcinog. 1990;3(6):393-402. doi: 10.1002/mc.2940030612.
9
Activating mutations of the c-Ha-ras protooncogene in chemically induced hepatomas of the male B6C3 F1 mouse.雄性B6C3 F1小鼠化学诱导肝癌中c-Ha-ras原癌基因的激活突变
Proc Natl Acad Sci U S A. 1986 Aug;83(16):5825-9. doi: 10.1073/pnas.83.16.5825.
10
Three different activated ras genes in mouse tumours; evidence for oncogene activation during progression of a mouse lymphoma.小鼠肿瘤中三种不同的活化ras基因;小鼠淋巴瘤进展过程中癌基因活化的证据。
EMBO J. 1984 Apr;3(4):913-7. doi: 10.1002/j.1460-2075.1984.tb01905.x.

引用本文的文献

1
Identification of a novel variant and its association with papillary thyroid carcinoma.一种新型变体的鉴定及其与甲状腺乳头状癌的关联。
Oncol Lett. 2018 Apr;15(4):4511-4516. doi: 10.3892/ol.2018.7818. Epub 2018 Jan 17.
2
Carbonic anhydrase 2 is a novel invasion-associated factor in urinary bladder cancers.碳酸酐酶2是膀胱癌中一种新的侵袭相关因子。
Cancer Sci. 2017 Mar;108(3):331-337. doi: 10.1111/cas.13143.
3
Neoadjuvant paradigm for accelerated drug development: an ideal model in bladder cancer.新辅助范式加速药物研发:膀胱癌的理想模型。
Oncologist. 2013;18(8):933-40. doi: 10.1634/theoncologist.2013-0023. Epub 2013 Jul 24.
4
Lack of mutational events of RAS genes in sporadic thyroid cancer but high risk associated with HRAS T81C single nucleotide polymorphism (case-control study).散发性甲状腺癌中RAS基因无突变事件,但HRAS T81C单核苷酸多态性与之相关的高风险(病例对照研究)。
Tumour Biol. 2013 Feb;34(1):521-9. doi: 10.1007/s13277-012-0577-y. Epub 2012 Nov 13.
5
What are we learning from the cancer genome?我们从癌症基因组中学到了什么?
Nat Rev Clin Oncol. 2012 Nov;9(11):621-30. doi: 10.1038/nrclinonc.2012.159. Epub 2012 Sep 11.
6
CXCL17 expression by tumor cells recruits CD11b+Gr1 high F4/80- cells and promotes tumor progression.肿瘤细胞表达的 CXCL17 募集 CD11b+Gr1 high F4/80-细胞,并促进肿瘤进展。
PLoS One. 2012;7(8):e44080. doi: 10.1371/journal.pone.0044080. Epub 2012 Aug 29.
7
Chemopreventive efficacy of Atorvastatin against nitrosamine-induced rat bladder cancer: antioxidant, anti-proliferative and anti-inflammatory properties.阿托伐他汀对亚硝胺诱导的大鼠膀胱癌的化学预防作用:抗氧化、抗增殖和抗炎特性。
Int J Mol Sci. 2012;13(7):8482-8499. doi: 10.3390/ijms13078482. Epub 2012 Jul 9.
8
G4-DNA formation in the HRAS promoter and rational design of decoy oligonucleotides for cancer therapy.G4-DNA 在 HRAS 启动子中的形成及用于癌症治疗的 decoys 寡核苷酸的合理设计。
PLoS One. 2011;6(9):e24421. doi: 10.1371/journal.pone.0024421. Epub 2011 Sep 8.
9
Spotlight on differentially expressed genes in urinary bladder cancer.聚焦膀胱癌中差异表达的基因。
PLoS One. 2011 Apr 5;6(4):e18255. doi: 10.1371/journal.pone.0018255.
10
Molecular genesis of non-muscle-invasive urothelial carcinoma (NMIUC).非肌肉浸润性膀胱癌(NMIUC)的分子发生机制。
Expert Rev Mol Med. 2010 Mar 25;12:e10. doi: 10.1017/S1462399410001407.